Home › Profile of hepatitis C and injection drug use in Canada: a discussion paper

Profile of hepatitis C and injection drug use in Canada: a discussion paper

Tagged :
Print
Text Size: Normal / Medium / Large
Printer-friendly versionPrinter-friendly version
Resource Language: 
English
Media Type: 
Paper
Online
Author: 
Jamie Wiebe
Bette Reimer
Health Canada, Population and Public Health Branch, Centre for Infectious Disease Prevention and Control, Community Acquired Infections Division, Hepatitis C Prevention, Support and Research Program
Canadian Centre on Substance Abuse
Publisher: 
Health Canada, Population and Public Health Branch, Centre for Infectious Disease Prevention and Control, Hepatitis C Division
Publication Date: 
2000
Publication Place: 
Ottawa, ON

Summarises available information regarding the prevalence of heptatis C virus (HCV) infection and injection drug use (IDU) in Canada, demographic characteristics of those in Canada who inject drugs, and the identification of high-risk behaviours. Intended to raise awareness and understanding of HCV infection among IDU populations in Canada and thereby provide direction for future initiatives and programming in efforts to reduce the spread of hepatitis C in this country.

Available From: 
Hepatitis C Prevention, Support and Research Program
ISBN/ISSN: 
HEST.W54 2000
URLs: 
http://www.hc-sc.gc.ca/hppb/hepatitis_c/pdf/careDiscCanada.pdf
http://www.hc-sc.gc.ca/hppb/hepatitis_c/pdf/careDiscCanada/index.html